Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04829357 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Post Market Clinical Follow-up Study on TVT ABBREVO® Continence System

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

The 50 most recent of 62 record versions are accounted for below. See every version on ClinicalTrials.gov ↗

  1. 2 versions Re-verified since Jun 4, 2026, no change to tracked fieldsv61-v62
  2. Primary completion moved earlier from Sep 30, 2036 to Dec 31, 2033
    • Study completion pushed from Feb 27, 2037 to Dec 31, 2038
    v60
  3. Primary completion pushed from Dec 31, 2033 to Sep 30, 2036
    • Study completion moved earlier from Dec 31, 2038 to Feb 27, 2037
    v59
  4. Primary completion date: Sep 30, 2036 to Dec 31, 2033
    • Study completion date: Feb 27, 2037 to Dec 31, 2038
    v58
  5. Re-verified, no change to tracked fieldsv57
Show 44 earlier versionsHide 44 earlier versions
  1. Study sites: 5 to 4v56
  2. 16 versions Re-verified since Aug 12, 2024, no change to tracked fieldsv40-v55
  3. Primary completion date: Sep 30, 2035 to Sep 30, 2036
    • Study completion date: Feb 27, 2036 to Feb 27, 2037
    • Site details revised at 1 of 5 sites
    v39
  4. 12 versions Re-verified since Jul 18, 2023, no change to tracked fieldsv27-v38
  5. Primary completion date: Sep 30, 2032 to Sep 30, 2035
    • Study completion date: Feb 27, 2033 to Feb 27, 2036
    • Study sites revised (5)
    v26
  6. 6 versions Re-verified since Dec 27, 2022, no change to tracked fieldsv20-v25
  7. Site details revised at 1 of 5 sitesv19
  8. 6 versions Re-verified since May 16, 2022, no change to tracked fieldsv13-v18
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Ethicon, Inc.
9 trials monitored
See 1 trial at risk
The objective of this single arm, post market, clinical study is to evaluate the performance of Gynecare TVT ABBREVO® Continence System in women undergoing Mid-urethral sling surgery for Stress Urinary Incontinence (SUI).
Trial Details
NCT Number NCT04829357
Lead Sponsor Ethicon, Inc.
Conditions
(from sponsor)		 Stress Urinary Incontinence
Related terms Urinary Incontinence, Stress
Enrollment 195 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov